Efficacy, safety and acceptability of the new pen needle 34G × 3.5 mm: a cross-over randomized non-inferiority trial; AGO 02 study.

CONCLUSIONS: The 34Gx3.5 mm needle was non-inferior to the 32Gx4 mm needle regarding fructosamine levels and glycemic variability supporting the suitability of the 34Gx3.5 mm needle for insulin injection in patients with diabetes. PMID: 29924641 [PubMed - as supplied by publisher]
Source: Current Medical Research and Opinion - Category: Research Tags: Curr Med Res Opin Source Type: research